Corcept Therapeutics (CORT) reports insider trading on August 26, 2025

Corcept Therapeutics (CORT) experienced insider trading activity on 8/26/2025, with a total of 3 insider trades occurring on that day. The transactions involved the Chief Business Officer, Robb Gary Charles, engaging in both selling and buying shares. On 8/26/2025, Robb Gary Charles sold 26,747 shares at a price of $471.17 per share, totaling $190.31k. Subsequently, he bought 5,000 shares at a price of $3.88 per share, amounting to $19.4k. Finally, on the same day, Robb Gary Charles sold another 23,671 shares at $271.27 per share, totaling $165.77k.

Prior to these transactions, on 8/12/2025, the Chief Development Officer, Guyer William, was also involved in insider trading. Guyer William sold 35,000 shares at a price of $771.77 per share, totaling $2,512.45k. He then bought 35,000 shares at a price of $721.65 per share, amounting to $757.9k. Additionally, on 8/7/2025, Guyer William engaged in insider trading by selling 147 shares at $1.77 per share, totaling $1.0k, and buying 142 shares at $1.65 per share, amounting to $0.3k.

Furthermore, on 8/5/2025, the President of Corcept Endocrinology, Maduck Sean, participated in insider trading activities. Maduck Sean sold 27,865 shares at a price of $67.53 per share, totaling $1,881.82k. He then bought 35,000 shares at a price of $75.05 per share, amounting to $176.79k. Finally, on the same day, Maduck Sean sold an additional 54,286 shares at $68.52 per share, totaling $371.95k.

Corcept Therapeutics Incorporated, established in Delaware on May 13, 1998, is a company dedicated to the discovery and development of medications that target severe endocrinologic, oncologic, metabolic, and neurologic disorders by influencing the effects of the hormone cortisol. The company remains engaged in producing innovative solutions to address a variety of critical health conditions.

In conclusion, insider trading activities within Corcept Therapeutics have been observed on multiple occasions, involving key figures within the company. These transactions provide insight into the movement of shares and decisions made by individuals in leadership roles. Such occurrences within a company offer a glimpse into its operational dynamics and potential strategies moving forward. It is essential for investors and stakeholders to monitor these activities as they can impact the overall performance and trajectory of the company in the market.